TNFRSF9 and neoplasm: Benefiting from the high binding affinity of AP203 to PD-L1 and its potent agonism to CD137, AP203 can crosslink PD-L1 on tumor cells and CD137 on T cells to stabilize the immune synapses and further promote the activation of T cells.